Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04240041
Other study ID # TCD/PT-GA
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 10, 2019
Est. completion date July 2020

Study information

Verified date January 2020
Source Ain Shams University
Contact Ayat Allah Mahmoud, MB BCh
Phone 01030717379
Email Drayaghoneim15@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pregnant women at 32-36 weeks gestational age with sure gestational dating (based in both last menstrual period and dating ultrasound) and otherwise normal singleton pregnancy will be recruited. Ultrasonographic estimation of gestational age using combined transcerebellar diameter and placental thickness will be compared to the actual estimated gestational age.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date July 2020
Est. primary completion date July 2020
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 39 Years
Eligibility Inclusion Criteria:

- Sure of dates

- Have dating ultrasound with crown rump length between (9 to 12 )weeks

- No hormonal contraception 3 months before conception.

- Regular menstrual cycles.

- Medically free.

- Single pregnancy

- Gestational age 32-36 weeks

Exclusion Criteria:

- Irregular menstrual cycles and not sure of dates

- Multiple pregnancy.

- Fetal anomalies.

- Placenta previa, placental anomalies and poor visualization of the placenta

- Fetal growth restriction

- Pregnant women with medical disorder e.g. diabetes mellitus, Pre-eclampsia, Systemic lupus erythromatosis, hypertension.

Study Design


Related Conditions & MeSH terms

  • Gestational Age and Weight Conditions

Intervention

Diagnostic Test:
Transcerebellar diamater
Using SAMSUNG H60 convex probe 2-8 MHz Machine by the same sonographer, trans-cerebellar diameter is identified by obtaining an oblique view through posterior fossa that included visualization of midline thalamus, cerebellar hemispheres and cisterna magna.
Placental thickness
Using SAMSUNG H60 convex probe 2-8 MHz Machine by the same sonographer, placental thickness will be measured at the level of the umbilical cord insertion excluding the myometrium and sub-placental veins

Locations

Country Name City State
Egypt Ain Shams Maternity Hospital Cairo Abbsia

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concordance between estimated gestational age and combined transcerebellar diameter and placental thickness estimation Concordance between the estimated gestational age using last menstrual period and dating ultrasound; and that estimated using combination of transcerebellar diameter and placental thickness 32-36 weeks gestational age
See also
  Status Clinical Trial Phase
Recruiting NCT05757167 - Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics Phase 4
Recruiting NCT03732937 - Estimation of Gestational Age by TCD
Completed NCT02408783 - Simplified Gestational Age Score N/A
Active, not recruiting NCT01894139 - An Optimized Programming of Healthy Children (APPROACH) N/A
Recruiting NCT05492708 - The Heartland Study
Completed NCT04954807 - Indonesia After Discharge LBW Infant HMF Supplementation Study N/A
Recruiting NCT05042427 - Pregnancy Weight Management Health Literacy Questionnaire